Moneycontrol PRO
you are here: HomeNewsIndia

India Inc staring at 15% profit erosion in FY21, 10% revenue decline: CRISIL

Loan servicing can become difficult as a result of the troubles, its research wing said, estimating banks' non-performing assets (NPAs) to rise by up to 2 percentage points to 11.5 percent, and credit growth to slow down to 2 percent.

April 30, 2020 / 03:54 PM IST

India Inc is staring at a bleak and forgettable fiscal year FY21, which is likely to see a 10 percent fall in revenues and at least 15 percent erosion in profits due to the COVID-19 pandemic, domestic ratings agency CRISIL said on Thursday.

Loan servicing can become difficult as a result of the troubles, its research wing said, estimating banks' non-performing assets (NPAs) to rise by up to 2 percentage points to 11.5 percent, and credit growth to slow down to 2 percent.

At present, the country is under a 40-day lockdown till May 3, and there are indications of it being gradually withdrawn.

CRISIL estimated one month of the lockdown to shave off 3 percentage points from the gross domestic product (GDP) and warned that its base case of 1.8 percent growth for FY21 may fall to zero if the lockdown continues.

Coronavirus India LIVE Updates


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Its chief economist Dharmakirti Joshi said up to 4 percent of the GDP will be lost permanently as a result of the crisis, which will lead to scores getting unemployed.

He said the fiscal support worth Rs 1.7 lakh crore announced till now is inadequate to fight the crisis.

CRISIL expects a doubling of the stimulus to Rs 3.5 lakh crore with a focus on the industries segment in the second phase. Apart from the spending measures, there can be others like loan guarantees also, it said.

Joshi explained that countries having more fiscal space can afford to have longer lockdowns, while those like India with limited room will have to gradually open up to support the economy, and added that the containment measures should ease off by June.

However, the agency seemed to suggest that India Inc will be badly impacted due to the crisis.

“This is unprecedented and the numbers that we are estimating are historic, which you would like to forget sooner,” CRISIL Research's senior director Prasad Koparkar said.

Koparkar said CRISIL did an analysis of 800 firms across sectors and came out with estimates for the FY21.

It expects India Inc's revenue growth to fall 8-10 percent in the base case of 1.8 percent growth and slide further to 12-15 percent if the GDP is stagnant.

The more pronounced impact will be on profitability as it expects a 15-18 percent decline in operating profit margins in the base case, which can go up to 30 percent in the downside scenario.

As a result of this, credit metrics are set to weaken during the fiscal, CRISIL said, pointing out that the level of the Rs 16 lakh crore corporate debt that stands the risk of slipping into being stressed will go up to 32 percent from the earlier level of 22 percent.

Koparkar said bank credit growth will slow down to 2-3 percent and the retail segment, which had held on in the last few years, will also slow down as housing, auto and commercial vehicle sales suffer.

The heightened stress and the slow credit growth will take the overall NPAs to up to 11.5 percent, a level last seen in FY18 after the asset quality review of the Reserve Bank of India (RBI).

The NPAs will be higher both on fresh slippages and also slower resolutions through mechanisms like National Company Law Tribunals, it said.

Without giving a number, Koparkar said NPAs in the retail segment will also rise as the spectre of unemployment plays out.

From a sectoral perspective, it said auto components, real estate, gems and jewellery, construction, airlines, textiles, poultry and meat business will suffer the most, while pharma, telecom and direct to home players in media will be the least impacted.

For telecom, the research is estimating a double-digit revenue growth on the back of the 40 percent hike in tariffs last year, Koparkar said.

Follow our full coverage of the coronavirus pandemic here.
first published: Apr 30, 2020 03:45 pm
ISO 27001 - BSI Assurance Mark